Grayanoids are characteristic metabolites of Rhododendron plants and possess diverse structures and significant biological activities[@b1]. In particular, grayanoids with a wide spectrum of biological activities, such as sodium-channel-modulating[@b2], analgesic[@b3], sedative[@b4], and insect antifeedant activities[@b5], have been isolated from plants of the Rhododendron genus in recent years. Ten types of grayanane-related carbon skeletons have been reported, including grayanane (A-*nor*-B-*homo ent*-kaurane)[@b6], 1,5-secograyanane[@b7], 3,4-secograyanane[@b8], 9,10-secograyanane[@b9], 1,10:2,3-disecograyanane[@b10], leucothane (A-*homo*-B-*nor* grayanane)[@b11], kalmane (B-*homo*-C-*nor* grayanane)[@b12], 1,5-seco kalmane[@b13], micranthane (C-*homo* grayanane)[@b14], and mollane (C-*nor*-D-*homo* grayanane)[@b15]. We previously reported mollolide A, a grayanoid with a new 1,10:2,3-disecograyanane skeleton[@b10], and mollanol A, the first example with a C-*nor*-D-*homo* grayanane carbon skeleton[@b15], from *Rhododendron molle* G. Don, a plant that is used in traditional Chinese medicine as an anodyne and anesthetic[@b16]. In our continuing efforts to identify structurally interesting and biologically important grayanoids, two new grayanoids, rhodomollin A (**1**) and rhodomollin B (**2**), possessing an unprecedented D-*homo* grayanane (featured a 5/7/6/6-fused ring system) carbon skeleton, were isolated from the fruits of *R. molle*. Herein, the isolation, structural elucidation, and evaluation of the anti-viral activity of these compounds are discussed.

Results and Discussion
======================

Rhodomollin A (**1**) was obtained as a colorless crystal, and its molecular formula was determined to be C~20~H~30~O~5~ with six degrees of unsaturation based on HRESIMS analysis (*m/z* 373.1988 \[M + Na\]^+^, calcd 373.1985), consistent with the ^1^H and ^13^C NMR data. The IR spectrum included a strong absorption band at 3424 cm^−1^, indicative of the presence of hydroxy group(s). Analysis of the ^13^C NMR (DEPT) data led to the assignment of four methyls, three methylenes, eight methines (three oxygenated, two olefinic carbons), and five quaternary carbons (three oxygenated) (see [Table 1](#t1){ref-type="table"}). The two olefinic carbons accounted for only one of the six degrees of unsaturation; thus, five rings should be present. Detailed analysis of the ^1^H and ^13^C data of **1** indicated that **1** shares partial structural features (rings A, B and C in [Fig. 1](#f1){ref-type="fig"}) with previously reported grayanane-type diterpenoids.

The two gem-dimethyl singlets (*δ*~H~ 1.51, H~3~-18; 1.47, H~3~-19) were chosen as the starting point for the structural elucidation of ring A. The HMBC correlations from H~3~-18/H~3~-19 to C-3/C-4/C-5, from H-2 to C-5, and from H-3 to C-1 (see [Fig. 2](#f2){ref-type="fig"}) and the assignments of fragment a \[C(1)H−C(2)H−C(3)H\] by ^1^H−^1^H COSY and HSQC established the five-membered ring A.

Ring B was elucidated by the HMBC correlations from H-6 to C-1, C-5 and C-10, from H~3~-20 to C-1 and C-10, and from H-2 to C-1, C-5, and C-10. Because the five oxygen atoms in the molecular formula accounted for the six oxygenated carbons in the ^13^C-NMR spectrum and H-6 was correlated to C-10 in the HMBC spectrum, ring B was determined to be a furan ring formed through a C6-O-C10 oxygen bridge and fused with ring A at C-1 and C-5. The HMBC correlations from H~3~-20 to C-9 and from H~2~-7 to C-8/C-9 together with spin system b, C(6)H-C(7)H~2~, indicated that ring C shares the C6-O-C10 oxygen bridge with ring B to form a pyran ring.

The HMBC correlations from H-14 to C-8 and C-9 and from H-9 to C-14, together with spin system c elucidated from the ^1^H-^1^H COSY and HSQC spectra, established a six-membered ring (ring D in [Fig. 1](#f1){ref-type="fig"}). In addition, the HMBC correlations from H~2~-15 to C-8, C-9, and C-14 indicated the linkage of C-15 and C-8. The HMBC correlations from H-12 to C-16 and C-15 confirmed the connectivity of C-16 and C-12. Thus, another six-membered ring (ring E) was established. Subsequently, the HMBC correlations from H~3~-17 to C-12, C-15, and C-16 unambiguously placed CH~3~-17 on C-16.

Consequently, the planar structure of **1** was determined and features a 5/5/6/6/6-fused ring system. Rings D and E compose a bicyclo\[2.2.2\]octane ring system in which C-8 and C-12 are bridged by C-15 and C-16. This is the first example of a D-*homo* grayanane carbon skeleton.

The relative configurations were determined by NOESY correlations ([Fig. 2](#f2){ref-type="fig"}). NOESY correlations of H-3/H-1 and OH-3/H~3~-19 revealed the *α*-orientation of H-1 and H-3. NOESY correlations between H-1 and H-14 confirmed that the C14-C8 bond was also *α*-oriented, indicating that bond C8-C15 is *β*-configured. Additionally, H-12 must adopt an *α*-orientation in the rigid bicyclo\[2.2.2\]octane ring system formed by rings D and E. NOESY correlations of H-7b/H-9, H-9/H-15a, and H-9/OH-16 indicated that H-9, OH-16, H-15a, and H-7b are on the same side with a *β*-configuration.

The NOESY correlations of OH-5/H-1 and OH-5/H~3~-18 suggested that the two five-membered rings A and B were *cis*-fused to form a bicyclo\[3.3.0\]octane. The *cis*-fusion of rings A and B is preferred in bicyclo\[3.3.0\]octane because the *trans*-fusion of two five-membered rings would involve considerable torsional strain, with a very large enthalpy difference (*cis* to *trans* 29.6 kJ/mol)[@b17]. Due to a lack of NOE evidence, the relative configuration of the C6-O-C10 oxygen bridge could not be assigned directly by NOESY. Fortunately, a high-quality single crystal of **1** was obtained from a methanol-water solvent system. The X-ray crystallographic (Cu Kα radiation) data ([Table S1--S4](#S1){ref-type="supplementary-material"}) corroborated the planar structure and the relative configuration of **1** and further allowed the assignment of its absolute configuration as 1*R*, 2*R*, 3*R*, 5*S*, 6*R*, 8*R*, 9*R*, 10*S*, 12*R*, 16*S* \[with a Flack parameter of 0.05 (10)\] (see [Fig. 3](#f3){ref-type="fig"}). The crystallographic data for **1** have been deposited at the Cambridge Crystallographic Data Centre (CCDC) under deposition number 1445432.

Rhodomollin B (**2**) was obtained as white amorphous powder. Its molecular formula, C~20~H~30~O~5~, as deduced from HRESIMS, is identical to that of **1**. The UV, IR, and NMR spectral data of **2** also resembled those of **1**, except that compared with **1**, the ^13^C NMR signals for C-15 and C-17 in **2** were downshifted 1.5 ppm and upshifted 2.3 ppm, respectively. Careful analysis of the spectroscopic data allowed us to conclude that its planar structure was identical to that of **1**.

The NOESY correlations of H-1/H-3, H-1/H-14, H-9/H-7b, H-9/H-15a, and OH-5/H~3~-18 revealed that the two compounds share the same relative configurations in these positions, except the stereochemistry at C-16. The relative configuration of OH-16 was then confirmed to be *α*-oriented on the basis of the NOESY correlation between H-9 (*β*) and H~3~-17, indicating that **2** is a C-16 diastereomer of **1**. Thus, the structure of **2** was established and named rhodomollin B.

Rhodomollins A (**1**) and B (**2**) represent a new tetracyclic diterpene carbon skeleton with an unprecedented D-*homo* grayanane (featured a 5/7/6/6-fused ring system) carbon skeleton. We have named this new skeleton "rhodomollane". Compound **1** possesses an unusual *β-*16-OH. The stereochemistry at C-16 in grayanoids is highly conserved. A likely biosynthetic pathway is proposed in [Fig. 4](#f4){ref-type="fig"}. Compounds **1** and **2** share a common precursor i, which undergoes a C13-alkyl shift to form a carbocation center at C-16[@b18]. The carbocation center at C-16 can then be attacked by H~2~O from two sites to form diastereomers **1** and **2**.

The anti-viral activities of rhodomollins A (**1**) and B (**2**) were assessed *in vitro* in A/95-359 influenza virus-infected MDCK cells. Rhodomollin B (**2**) exhibited modest activity against influenza virus A/95-359, with an IC~50~ value of 19.24 *μ*M, whereas rhodomollin A (**1**) was inactive (IC~50~ \> 100 *μ*M).

Materials and Methods
=====================

General experimental procedures
-------------------------------

Optical rotations were measured with a PE model 343 polarimeter. CD spectra were recorded on a JASCO-815 CD spectrometer. A Nicolet 5700 FT-IR microscope instrument was used to record IR spectra. NMR spectra were obtained on INOVA-500 spectrometer. ESIMS were measured with an Agilent 1100 Series LC/MSD Trap mass spectrometer. HRESIMS data were measured using an Agilent 6520 Accurate-Mass Q-TOF LC/MS spectrometer. X-ray experiments were carried on a Gemini E X-ray single crystal diffractometer. A preparative Shimadazu LC-6AD HPLC equipped with SPD-20A and RID-10A detectors (Kyoto, Japan) along with an YMC ODS-A column (250 × 20 mm, 5 *μ*m, Kyoto, Japan) were used to purify the compounds. Macroporous resin (D101 type, The Chemical Plant of NanKai University, China), MCI gel, Mitsubishi chemical corporation, Sepherdex LH-20, GE chemical corporation, Si gel (160--200, 200--300 mesh, Qingdao Marine Chemical Factory, China) and ODS (50 *μ*m, Merck, Germany) were used for column chromatography (CC). TLC was carried out with precoated Si gel plates (Qingdao Marine Chemical Factory, China). Spots were visualized by spraying with 10% EtOH-sulfuric reagent; see [supplementary information S4](#S1){ref-type="supplementary-material"}.

Plant material
--------------

The fruits of *Rhododendron molle* were collected in Guangxi Province of China, in 2012. It was authenticated by Guang-Zhao Li, a professor of Guangxi Institute of Botany. A voucher specimen (ID-s-2445) was deposited in the herbarium of our institute (Institute of Materia Medica, Chinese Academy of Medical Sciences); see [supplementary information S4](#S1){ref-type="supplementary-material"}.

Extraction and isolation
------------------------

Extracts from the dried fruits of *Rhododendron molle* (100 kg) were obtained (2 h per extraction) with EtOH-H~2~O (95:5, v/v) under conditions of reflux. The extract was suspended in 30 L of H~2~O, and then partitioned with petroleum ether, CH~2~Cl~2~, EtOAc and MeOH (three times with 15 L each). The EtOAc fraction was then further separated on a macroporous resin column and eluted in a gradient of H~2~O:EtOH (70:30, 40:60, 5:95, v/v) in order of increasing concentrations of EtOH. The 30% EtOH fraction was further resolved on a MCI gel column and eluted in a gradient of MeOH:H~2~O (1:9--10:0, v/v) to obtain 15 fractions (EM~1~--EM~15~). Fraction EM~9~ was purified by Sephadex LH-20 column to obtain a terpenoid-containing fraction EM~9~G~1~ (9 g), which was further loaded onto an Si gel column and eluted in a gradient of CH~2~Cl~2~:MeOH (20:1--1:2, v/v) to obtain 10 fractions (EM~9~G~1~L~1~--EM~9~G~1~L~10~). EM~9~G~1~L~6~ (0.68 g) was purified by preparative HPLC and semi-preparative HPLC to yield **1** (6.0 mg). EM~9~G~1~L~7~ (0.55 g) was purified by preparative HPLC and semi-preparative HPLC to yield **2** (2.2 mg); see [supplementary information S5](#S1){ref-type="supplementary-material"}.

Rhodomollin A (1)
-----------------

Colorless crystals; \[α\]^20^~D~ + 7.1 (*c* 0.1, MeOH); UV (MeOH) λ~max~ (log *ε*) 204.8 (2.86) nm; IR(KBr) *ν*~max~ 3424, 2960, 2932, 1645, 1463, 1418, 1381, 1139, 1057, 1029, 984, 907, 875, 817, 798, 730, 665, 635 cm^−1^. For ^1^H and ^13^C NMR spectroscopic data, see [Table 1](#t1){ref-type="table"}; HRESI-MS 373.1986 (calcd for C~20~H~30~NaO~5~, 373.1985); see [supplementary information S6--S19](#S1){ref-type="supplementary-material"}.

Rhodomollin B (2)
-----------------

White powder; \[α\]^20^~D~ + 8.5 (*c* 0.14, MeOH); UV (MeOH) λ~max~ (log *ε*) 204.0 (2.9) nm; IR(KBr) ν~max~ 3374, 2931, 2872, 1597, 1443, 1379, 1123, 1081, 1050, 1129, 926, 910, 816, 732, 634 cm^−1^. For ^1^H and ^13^C NMR spectroscopic data, see [Table 1](#t1){ref-type="table"}; HRESI-MS 373.1986 (calcd for C~20~H~30~NaO~5~, 373.1985); see [supplementary information S20--S33](#S1){ref-type="supplementary-material"}.

Anti-influenza A Assays
-----------------------

Madin-Darby Canine Kidney (MDCK) cells and influenza A (A/Hanfang/359/95, H3N2) were from the Institute of Virology, Chinese Academy of Preventive Medicine. Confluent Madin-Darby Canine Kidney (MDCK) cells were infected with influenza A (A/Hanfang/359/95, H3N2) in 96-well microplates. After 2 h of viral adsorption (37 °C), the monolayers were washed by PBS and incubated with or without test compounds in the maintenance medium (37 °C). Cytopathogenic effect (CPE) caused by viral invasion was evaluated when the viral control group reached a level of 4 and the antiviral activity of test compounds was determined according to the Reed and Muench method[@b19][@b20][@b21].

The cytotoxicity of compounds in the presence of MDCK cells were monitored by CPE. MDCK cells (2.5 × 10^4^/well) were plated into a 96-well plate. A total of 24 h later, the monolayer cells were incubated in the presence of various concentrations of test compounds. The cells were cultured for 48 h at 37 °C and 5% CO~2~ in a carbon-dioxide incubator. CPE were counted on the infected MDCK cells. Median toxic concentration (TC~50~) values of test compounds were calculated by the method of Reed and Muench. Compounds **1** and **2** showed no cytotoxicicy in this assay (TC~50~ \> 100 *μ*M).
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###### NMR data for compounds 1 and 2 in C~5~D~5~N (*J* in Hz).

  No.                         1                        2                                        
  ------- ----------------------------------------- ------- ----------------------------------- -------
  1                     2.90 (d, 6.0)                57.0              2.88 (d, 6.0)             56.8
  2                       4.65 (m)                   78.0                4.65 (m)                78.0
  3                       4.66 (m)                   84.8                4.66 (m)                84.8
  4                          ---                     47.3                   ---                  47.3
  5                          ---                     89.3                   ---                  89.2
  6                    4.36 (brd, 4.5)               76.9             4.34 (brd, 4.5)            76.9
  7        a 2.57 (d, 13.5) b 1.92 (dd, 13.5, 4.5)   37.9          a 2.55 (m) b 1.86 (m)         38.1
  8                          ---                     37.6                   ---                  37.8
  9                       2.75 (m)                   49.4                2.07 (m)                49.1
  10                         ---                     83.5                   ---                  83.4
  11                a 2.76 (m) b 1.13 (m)            28.5          a 2.04 (m) b 1.13 (m)         28.9
  12                      2.50 (m)                   44.2                2.56 (m)                44.4
  13                 6.17 (dd, 8.0, 7.0)             131.4          4.32 (dd, 8.0, 6.5)          131.6
  14                    7.17 (d, 8.0)                141.3             7.27 (d, 8.0)             140.2
  15          a 1.81 (d, 12.0) b 1.54 (d, 12.0)      57.7    a 1.84 (d, 12.0) b 1.59 (d, 12.0)   59.2
  16                         ---                     73.4                   ---                  73.3
  17                      1.34 (s)                   33.0                1.55 (s)                30.7
  18                      1.51 (s)                   23.8                1.51 (s)                23.7
  19                      1.47 (s)                   18.4                1.48 (s)                18.4
  20                      1.54 (s)                   22.1                1.53 (s)                22.0
  OH-2                  6.52 (d, 4.0)                 ---               6.53 (brs)                ---
  OH-3                  6.66 (d, 5.0)                 ---               6.68 (brs)                ---
  OH-5                    6.22 (s)                    ---                6.23 (s)                 ---
  OH-16                   5.66 (s)                    ---                                           

Measured at 500 (^1^H) and 125 (^13^C) MHz. Overlapping signals are reported without designating multiplicity.
